September 26, 2016 — For men with intermediate-risk...
Prostate Cancer
News and new technology innovations concerning how imaging technology can help diagnose and treat prostate cancer can be found on this channel.
News | Radiopharmaceuticals and Tracers | September 07, 2016
September 7, 2016 — Blue Earth Diagnostics announced that the first post-U.S. Food and Drug Administration (FDA)...
ExactVu micro-ultrasound system image courtesy of Exact Imaging.
News | Prostate Cancer | August 08, 2016
July 28, 2016 — Exact Imaging announced that The Journal of Urology has published the initial results supporting the...
Images of prostate cells captured through photoacoustic imaging. Top: cancer cells that express the targeted cancer marker, PSMA; bottom: cells that lack PSMA. A research team led by Kent Nastiuk of Roswell Park Cancer Institute has published new evidence that this approach can be a useful tool in monitoring and selecting treatments for many cancers.
News | Prostate Cancer | July 15, 2016
While active surveillance is often recommended for patients with nonaggressive...
The figure shows a Gleason 3+4 prostate cancer (arrows) as identified on T2-weighted (A) and diffusion-weighted (B) MRI, F-18-choline PET (C), as well as PET/MRI (D).
News | Prostate Cancer | July 14, 2016
July 14, 2016 — Adding F-18-choline positron...
News | Prostate Cancer | July 13, 2016
July 13, 2016 — Overlake Medical Center, Bellevue, Wash., recently announced it is formally adopting a new standard...
News | Prostate Cancer | June 17, 2016
June 17, 2016 — Decatur Memorial Hospital, Decatur, Ill., is now offering C-11 choline...
Jeffrey Nix, M.D., left, and Soroush Rais-Bahrami, M.D., with the iSR’obotTM Mona Lisa , a new image guided device for diagnosing prostate cancer. Image courtesy of UAB News.
News | Biopsy Systems | June 09, 2016
June 9, 2016 — The University of Alabama at Birmingham (UAB) announced it is one of two beta sites in the United...
News | PET-CT | June 07, 2016
June 7, 2016 — A recent pilot study reported in the June issue of The Journal of Nuclear Medicine found that sodium...
Technology | Radiopharmaceuticals and Tracers | June 07, 2016
June 7, 2016 — Blue Earth Diagnostics Ltd. and Siemens’ PETNET Solutions Inc. announced the commercial availability...
The image on the left is a magnetic resonance image (MRI) of a prostate enhanced with restriction spectrum imaging (RSI). Higher grade tumor is indicated by orange and yellow. The image on the right is a digitized section of the prostate with the tumors outlined with blue dotted lines. Image courtesy of UC San Diego Health.
News | Prostate Cancer | June 02, 2016
June 2, 2016 — Physicians have long used...
News | Prostate Cancer | June 01, 2016
June 1, 2016 — A new Phase III clinical trial will look to evaluate if...
News | Prostate Cancer | May 18, 2016
May 18, 2016 — Rational Surgical Solutions announced at the American Urological Association 2016 Annual Meeting (...
News | Radiopharmaceuticals and Tracers | May 13, 2016
May 13, 2016 — Blue Earth Diagnostics, a molecular imaging diagnostics company, announced it has established...
Radiation dose is delivered by beams directed from many angles combined with implanted seeds (white spots). By integrating the two types of radiation, the highest dose is delivered only within the tumor. The external beams correct any irregularity from the seeds. Thanks to MRI planning, very little dose goes to critical adjacent structures. Image courtesy of University of Michigan Health System.
News | Prostate Cancer | May 12, 2016
May 12, 2016 — The prostate is a tiny organ surrounded by critical structures. When...
